Evidence map›Paper›PMID 42653166›Full record

ReviewInternational journal of molecular sciences2026

Pharmacological Modulators of TCTP: Opportunities and Challenges for Drug Repurposing.

Weronika Andrzejczyk, Klaudia Porębska, Thananjeyan Balasubramaniyam, Agnieszka Synowiec, Malgorzata Kloc, Paweł Stączek, Jacek Z Kubiak

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Weronika AndrzejczykMilitary Institute of Medicine-National Research Institute, Szaserów 128, 04-141 Warsaw, Poland.
Klaudia PorębskaMilitary Institute of Medicine-National Research Institute, Szaserów 128, 04-141 Warsaw, Poland.
Thananjeyan BalasubramaniyamMilitary Institute of Medicine-National Research Institute, Szaserów 128, 04-141 Warsaw, Poland.ORCID 0000-0003-1566-8970
Agnieszka SynowiecMilitary Institute of Medicine-National Research Institute, Szaserów 128, 04-141 Warsaw, Poland.
Malgorzata KlocTransplant Immunology, The Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0002-5192-8584
Paweł StączekDepartment of Molecular Microbiology, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.ORCID 0000-0003-4416-8289
Jacek Z KubiakMilitary Institute of Medicine-National Research Institute, Szaserów 128, 04-141 Warsaw, Poland.ORCID 0000-0003-2772-5127

Funding

Ministry of Science and Education, Poland 613/2023
6 · The paper itself

Abstract

Thanks to the rapid development of advanced analytical methods, researchers can now identify new, so far unknown applications for existing drugs. This expanding knowledge about the mechanisms of drug action, including interactions with various molecules and molecular pathways, not only enables more effective use of available therapies but also reduces both the time and cost of developing new therapeutic options. One of the proteins reported to interact with numerous drugs and chemicals is Translationally Controlled Tumor Protein (TCTP). Numerous studies have demonstrated that TCTP plays a crucial role in diverse biological processes, including cell growth, cell cycle regulation, cellular proliferation, allergic reactions, stress response, inhibition of apoptosis, calcium ion binding, interacting with microtubules and actin microfilaments, the progression of various cancers, and tumor reversion. Therefore, this review article aims to compile a list of drugs and substances shown to interact with TCTP and that, given TCTP's numerous cellular functions, could be repurposed for other therapies.

Indexed as

Antineoplastic AgentsBiomarkers, TumorDrug RepositioningNeoplasmsAnimalsHumansTumor Protein, Translationally-Controlled 1Antineoplastic AgentsBiomarkers, TumorTPT1 protein, humanTumor Protein, Translationally-Controlled 1cancerdTCTPfortilinHRFPLK1pTCTPsertralineTCTP

Identifiers

PMID42653166
PMCPMC13513372

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.